{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:42:52Z","timestamp":1794012172198,"version":"4.8.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["201440_Z_16_Z"],"award-info":[{"award-number":["201440_Z_16_Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Interest is growing in the role of infectious agents in the pathogenesis of dementia, but current evidence is limited. We conducted a systematic review and meta-analysis to investigate the effect of any of eight human herpesviruses on development of dementia or mild cognitive impairment (MCI). We searched the Cochrane Library, Embase, Global Health, Medline, PsycINFO, Scopus, Web of Science, clinical trials registers and grey literature sources from inception to December 2017 for observational studies with cohort, case control or self-controlled designs, or randomised controlled trials of interventions against herpesviruses. Pooled effect estimates and 95% confidence intervals (CIs) were generated through random effects meta-analyses across studies with the same design, outcome, and virus type, method and site of measurement. We included 57 studies across various geographic settings. Past infection with herpesviruses, measured by IgG seropositivity, was generally not associated with dementia risk. A single cohort study rated moderate quality showed an association between varicella zoster virus reactivation (ophthalmic zoster) and incident dementia (HR 2.97; 95%CI, 1.89 to 4.66). Recent infection with, or reactivation of, herpes simplex virus type 1 or type 1\/2 unspecified, cytomegalovirus and human herpes virus-6 measured by serum IgM, high titre IgG or clinical disease may be associated with dementia or MCI, though results were inconsistent across studies and overall evidence rated very low quality. Longitudinal population studies with robust repeated virus measurements taken sufficiently proximal to dementia onset are needed to establish whether, when and among whom herpesviruses affect dementia risk.<\/jats:p>","DOI":"10.1038\/s41598-019-41218-w","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T07:03:45Z","timestamp":1553065425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":125,"title":["Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"9","author":[{"given":"Charlotte","family":"Warren-Gash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet J.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8246-0534","authenticated-orcid":false,"given":"Judith","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique","family":"Mavrodaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil H.","family":"Ridha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin N.","family":"Rossor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Smeeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"issue":"8","key":"41218_CR1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","volume":"13","author":"S Norton","year":"2014","unstructured":"Norton, S., Matthews, F. E., Barnes, D. E., Yaffe, K. & Brayne, C. Potential for primary prevention of Alzheimer\u2019s disease: an analysis of population-based data. Lancet Neurol. 13(8), 788\u2013794 (2014).","journal-title":"Lancet Neurol."},{"issue":"1","key":"41218_CR2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-016-0188-8","volume":"8","author":"M Prince","year":"2016","unstructured":"Prince, M. et al. Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimers Res Ther. 8(1), 23 (2016).","journal-title":"Alzheimers Res Ther."},{"key":"41218_CR3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fphar.2012.00014","volume":"3","author":"E Solito","year":"2012","unstructured":"Solito, E. & Sastre, M. Microglia Function in Alzheimer\u2019s Disease. Front Pharmacol. 3, 14 (2012).","journal-title":"Front Pharmacol."},{"issue":"2","key":"41218_CR4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nri2015","volume":"7","author":"VH Perry","year":"2007","unstructured":"Perry, V. H., Cunningham, C. & Holmes, C. Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol. 7(2), 161\u20137 (2007).","journal-title":"Nat Rev Immunol."},{"key":"41218_CR5","first-page":"445","volume":"7","author":"BI Pereira","year":"2016","unstructured":"Pereira, B. I. & Akbar, A. N. Convergence of Innate and Adaptive Immunity during Human Aging. Front Immunol. 7, 445 (2016).","journal-title":"Front Immunol."},{"issue":"2\u20133","key":"41218_CR6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neulet.2007.09.077","volume":"429","author":"MA Wozniak","year":"2007","unstructured":"Wozniak, M. A., Itzhaki, R. F., Shipley, S. J. & Dobson, C. B. Herpes simplex virus infection causes cellular \u03b2-amyloid accumulation and secretase upregulation. Neurosci Lett. 429(2\u20133), 95\u2013100 (2007).","journal-title":"Neurosci Lett."},{"issue":"11","key":"41218_CR7","doi-asserted-by":"crossref","first-page":"e13989","DOI":"10.1371\/journal.pone.0013989","volume":"5","author":"G De Chiara","year":"2010","unstructured":"De Chiara, G. et al. APP Processing Induced by Herpes Simplex Virus Type 1 (HSV-1) Yields Several APP Fragments in Human and Rat Neuronal Cells. Blaho JA, editor. PLoS ONE. 5(11), e13989 (2010).","journal-title":"PLoS ONE."},{"issue":"5","key":"41218_CR8","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/jnr.23003","volume":"90","author":"G Alvarez","year":"2012","unstructured":"Alvarez, G., Aldudo, J., Alonso, M., Santana, S. & Valdivieso, F. Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells. J Neurosci Res. 90(5), 1020\u20139 (2012).","journal-title":"J Neurosci Res."},{"issue":"2","key":"41218_CR9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3233\/JAD-140822","volume":"47","author":"AJ Steel","year":"2015","unstructured":"Steel, A. J. & Eslick, G. D. Herpes Viruses Increase the Risk of Alzheimer\u2019s Disease: A Meta-Analysis. J Alzheimers Dis. 47(2), 351\u201364 (2015).","journal-title":"J Alzheimers Dis."},{"issue":"7","key":"41218_CR10","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6(7), e1000097 (2009).","journal-title":"PLoS Med."},{"issue":"6","key":"41218_CR11","doi-asserted-by":"crossref","first-page":"e016522","DOI":"10.1136\/bmjopen-2017-016522","volume":"7","author":"C Warren-Gash","year":"2017","unstructured":"Warren-Gash, C. et al. Association between human herpesvirus infections and dementia or mild cognitive impairment: a systematic review protocol. BMJ Open. 7(6), e016522 (2017).","journal-title":"BMJ Open."},{"key":"41218_CR12","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins, J. P. T. et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 343, d5928 (2011).","journal-title":"BMJ."},{"key":"41218_CR13","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne, J. A. et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 355, i4919 (2016).","journal-title":"BMJ."},{"key":"41218_CR14","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JAC Sterne","year":"2011","unstructured":"Sterne, J. A. C. et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 343, d4002 (2011).","journal-title":"BMJ."},{"issue":"7454","key":"41218_CR15","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"D Atkins","year":"2004","unstructured":"Atkins, D. et al. Grading quality of evidence and strength of recommendations. BMJ. 328(7454), 1490 (2004).","journal-title":"BMJ."},{"issue":"9112","key":"41218_CR16","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0140-6736(05)79057-7","volume":"351","author":"U Beffert","year":"1998","unstructured":"Beffert, U., Bertrand, P., Champagne, D., Gauthier, S. & Poirier, J. HSV-1 in brain and risk of Alzheimer\u2019s disease. Lancet. 351(9112), 1330\u20131 (1998).","journal-title":"Lancet."},{"key":"41218_CR17","first-page":"201","volume":"2","author":"P Bertrand","year":"1993","unstructured":"Bertrand, P. Distribution of herpes simplex virus type1 DNA in selected areas of normal and Alzheimer\u2019s disease brains: a PCR study. Neurodegeneration. 2, 201\u20138 (1993).","journal-title":"Neurodegeneration."},{"issue":"3","key":"41218_CR18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/1522-2683(200102)22:3<445::AID-ELPS445>3.0.CO;2-8","volume":"22","author":"MS Cheon","year":"2001","unstructured":"Cheon, M. S., Bajo, M., Gulesserian, T., Cairns, N. & Lubec, G. Evidence for the relation of herpes simplex virus type 1 to Down syndrome and Alzheimer\u2019s disease. Electrophoresis. 22(3), 445\u20138 (2001).","journal-title":"Electrophoresis."},{"issue":"3","key":"41218_CR19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2990.1990.tb01158.x","volume":"16","author":"AM Deatly","year":"1990","unstructured":"Deatly, A. M., Haase, A. T., Fewster, P. H., Lewis, E. & Ball, M. J. Human herpes virus infections and Alzheimer\u2019s disease. Neuropathol Appl Neurobiol. 16(3), 213\u201323 (1990).","journal-title":"Neuropathol Appl Neurobiol."},{"issue":"3","key":"41218_CR20","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3233\/JAD-170520","volume":"60","author":"AS Costa","year":"2017","unstructured":"Costa, A. S. et al. Modulation of Immune Responses to Herpes Simplex Virus Type 1 by IFNL3 and IRF7 Polymorphisms: A Study in Alzheimer\u2019s Disease. J Alzheimers Dis. 60(3), 1055\u201363 (2017).","journal-title":"J Alzheimers Dis."},{"issue":"9058","key":"41218_CR21","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0140-6736(05)62325-2","volume":"349","author":"S Itabashi","year":"1997","unstructured":"Itabashi, S., Arai, H., Matsui, T., Higuchi, S. & Sasaki, H. Herpes simplex virus and risk of Alzheimer\u2019s disease. Lancet. 349(9058), 1102 (1997).","journal-title":"Lancet."},{"issue":"2","key":"41218_CR22","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.1042\/bst019122s","volume":"19","author":"GA Jamieson","year":"1991","unstructured":"Jamieson, G. A., Maitland, N. J., Craske, J., Wilcock, G. K. & Itzhaki, R. F. Detection of herpes simplex virus type 1 DNA sequences in normal and Alzheimer\u2019s disease brain using polymerase chain reaction. Biochem Soc Trans. 19(2), 122S (1991).","journal-title":"Biochem Soc Trans."},{"issue":"4","key":"41218_CR23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/path.1711670403","volume":"167","author":"GA Jamieson","year":"1992","unstructured":"Jamieson, G. A., Maitland, N. J., Wilcock, G. K., Yates, C. M. & Itzhaki, R. F. Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. J Pathol. 167(4), 365\u20138 (1992).","journal-title":"J Pathol."},{"issue":"Suppl","key":"41218_CR24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0167-4943(05)80019-6","volume":"3","author":"G Jamieson","year":"1992","unstructured":"Jamieson, G., Maitland, N. & Itzhaki, R. Herpes simplex virus type-1 DNA sequences are present in aged normal and Alzheimer\u2019s disease brain but absent in lymphocytes. Arch Gerontol Geriatr. 3(Suppl), 197\u2013202 (1992).","journal-title":"Arch Gerontol Geriatr."},{"issue":"3","key":"41218_CR25","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbrc.2012.12.054","volume":"430","author":"N Kobayashi","year":"2013","unstructured":"Kobayashi, N. et al. Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer\u2019s disease. Biochem Biophys Res Commun. 430(3), 907\u201311 (2013).","journal-title":"Biochem Biophys Res Commun."},{"issue":"4","key":"41218_CR26","first-page":"274","volume":"1","author":"W Lin","year":"1998","unstructured":"Lin, W., Graham, J., MacGowan, S., Wilcock, G. & Itzhaki, R. Alzheimer\u2019s disease, herpes virus in the brain, apolipoprotein E4 and herpes labialis. Alzheimers Rep. 1(4), 274 (1998).","journal-title":"Alzheimers Rep."},{"issue":"1\u20133","key":"41218_CR27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02815215","volume":"28","author":"WR Lin","year":"1996","unstructured":"Lin, W. R., Shang, D. & Itzhaki, R. F. Neurotropic viruses and Alzheimer disease. Interaction of herpes simplex type 1 virus and apolipoprotein E in the etiology of the disease. Mol Chem Neuropathol. 28(1\u20133), 135\u201341 (1996).","journal-title":"Mol Chem Neuropathol."},{"key":"41218_CR28","first-page":"S47","volume":"15","author":"W Lin","year":"1994","unstructured":"Lin, W., Jamieson, G. & Itzhaki, R. The possible role of herpes-simplex virus type-1 in the etiology of Alzheimers-disease. Neurobiol Aging. 15, S47 (1994).","journal-title":"Neurobiol Aging."},{"issue":"3","key":"41218_CR29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/path.1127","volume":"197","author":"W-R Lin","year":"2002","unstructured":"Lin, W.-R., Wozniak, M. A., Cooper, R. J., Wilcock, G. K. & Itzhaki, R. F. Herpesviruses in brain and Alzheimer\u2019s disease. J Pathol. 197(3), 395\u2013402 (2002).","journal-title":"J Pathol."},{"issue":"1","key":"41218_CR30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/nbdi.2001.0465","volume":"9","author":"W-R Lin","year":"2002","unstructured":"Lin, W.-R., Wozniak, M. A., Wilcock, G. K. & Itzhaki, R. F. Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients. Neurobiol Dis. 9(1), 82\u20137 (2002).","journal-title":"Neurobiol Dis."},{"key":"41218_CR31","doi-asserted-by":"crossref","unstructured":"Mancuso, R. et al. HSV-1 specific IgG subclasses in individuals with Alzheimer\u2019s disease. Alzheimers Dement. 12(7 (supplement)), P1052\u20131053 (2016).","DOI":"10.1016\/j.jalz.2016.06.2196"},{"issue":"4","key":"41218_CR32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3233\/JAD-130977","volume":"38","author":"R Mancuso","year":"2014","unstructured":"Mancuso, R. et al. Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer\u2019s disease. J Alzheimers Dis. 38(4), 741\u20135 (2014).","journal-title":"J Alzheimers Dis."},{"key":"41218_CR33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fnagi.2014.00285","volume":"6","author":"R Mancuso","year":"2014","unstructured":"Mancuso, R. et al. Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer\u2019s disease and amnestic mild cognitive impairment. Front Aging Neurosci. 6, 285 (2014).","journal-title":"Front Aging Neurosci."},{"issue":"4","key":"41218_CR34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jmv.20133","volume":"73","author":"I Mori","year":"2004","unstructured":"Mori, I. et al. Reactivation of HSV-1 in the brain of patients with familial Alzheimer\u2019s disease. J Med Virol. 73(4), 605\u201311 (2004).","journal-title":"J Med Virol."},{"issue":"2","key":"41218_CR35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/jnnp.49.2.216","volume":"49","author":"GW Roberts","year":"1986","unstructured":"Roberts, G. W. et al. Herpes simplex virus: a role in the aetiology of Alzheimer\u2019s disease? J Neurol Neurosurg Psychiatry. 49(2), 216 (1986).","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"2","key":"41218_CR36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/jmv.20271","volume":"75","author":"MA Wozniak","year":"2005","unstructured":"Wozniak, M. A., Shipley, S. J., Combrinck, M., Wilcock, G. K. & Itzhaki, R. F. Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer\u2019s disease patients. J Med Virol. 75(2), 300\u20136 (2005).","journal-title":"J Med Virol."},{"issue":"1","key":"41218_CR37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/path.2449","volume":"217","author":"MA Wozniak","year":"2009","unstructured":"Wozniak, M. A., Mee, A. P. & Itzhaki, R. F. Herpes simplex virus type 1 DNA is located within Alzheimer\u2019s disease amyloid plaques. J Pathol. 217(1), 131\u20138 (2009).","journal-title":"J Pathol."},{"issue":"12","key":"41218_CR38","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/ene.12477","volume":"22","author":"X-L Bu","year":"2015","unstructured":"Bu, X.-L. et al. A study on the association between infectious burden and Alzheimer\u2019s disease. Eur J Neurol. 22(12), 1519\u201325 (2015).","journal-title":"Eur J Neurol."},{"issue":"12","key":"41218_CR39","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/cns.12632","volume":"22","author":"Y-M Deng","year":"2016","unstructured":"Deng, Y.-M. et al. A Case-Control Study: Infectious Burden Increased the Occurrence of Vascular Cognitive Impairment No Dementia. CNS Neurosci Ther. 22(12), 1012\u20134 (2016).","journal-title":"CNS Neurosci Ther."},{"issue":"2","key":"41218_CR40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ana.10662","volume":"54","author":"N Hemling","year":"2003","unstructured":"Hemling, N. et al. Herpesviruses in brains in Alzheimer\u2019s and Parkinson\u2019s diseases. Ann Neurol. 54(2), 267\u201371 (2003).","journal-title":"Ann Neurol."},{"key":"41218_CR41","first-page":"344","volume":"229","author":"R Itzhaki","year":"2005","unstructured":"Itzhaki, R., Wozniak, M., Wilcock, G. & Lin, W. The role of viruses in dementia: Detection of cytomegalovirus DNA in brain of vascular dementia patients. J Neurol Sci. 229, 344\u20135 (2005).","journal-title":"J Neurol Sci."},{"issue":"1","key":"41218_CR42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0167-4943(92)90038-6","volume":"15","author":"SD Kittur","year":"1992","unstructured":"Kittur, S. D. et al. A molecular hybridization study for the presence of Herpes simplex, cytomegalovirus and Epstein-Barr virus in brain and blood of Alzheimer\u2019s disease patients. Arch Gerontol Geriatr. 15(1), 35\u201341 (1992).","journal-title":"Arch Gerontol Geriatr."},{"issue":"1","key":"41218_CR43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-160563","volume":"55","author":"S-M Shim","year":"2017","unstructured":"Shim, S.-M. et al. Elevated Epstein-Barr Virus Antibody Level is Associated with Cognitive Decline in the Korean Elderly. J Alzheimers Dis. 55(1), 293\u2013301 (2017).","journal-title":"J Alzheimers Dis."},{"issue":"5","key":"41218_CR44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/jcla.1860040510","volume":"4","author":"A Ounanian","year":"1990","unstructured":"Ounanian, A., Guilbert, B., Renversez, J. C., Seigneurin, J. M. & Avrameas, S. Antibodies to viral antigens, xenoantigens, and autoantigens in Alzheimer\u2019s disease. J Clin Lab Anal. 4(5), 367\u201375 (1990).","journal-title":"J Clin Lab Anal."},{"issue":"2","key":"41218_CR45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1017\/S0033291700009107","volume":"16","author":"GR Taylor","year":"1986","unstructured":"Taylor, G. R. & Crow, T. J. Viruses in human brains: a search for cytomegalovirus and herpes virus 1 DNA in necropsy tissue from normal and neuropsychiatric cases. Psychol Med. 16(2), 289\u201395 (1986).","journal-title":"Psychol Med."},{"key":"41218_CR46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fneur.2017.00040","volume":"8","author":"G Westman","year":"2017","unstructured":"Westman, G. et al. Decreased HHV-6 IgG in Alzheimer\u2019s Disease. Front Neurol. 8, 40 (2017).","journal-title":"Front Neurol."},{"issue":"1","key":"41218_CR47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3233\/JAD-150464","volume":"49","author":"S Agostini","year":"2016","unstructured":"Agostini, S. et al. Lack of evidence for a role of HHV-6 in the pathogenesis of Alzheimer\u2019s disease. J Alzheimers Dis. 49(1), 229\u201335 (2016).","journal-title":"J Alzheimers Dis."},{"key":"41218_CR48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbi.2016.07.153","volume":"58","author":"S Agostini","year":"2016","unstructured":"Agostini, S. et al. High avidity HSV-1 antibodies correlate with absence of amnestic Mild Cognitive Impairment conversion to Alzheimer\u2019s disease. Brain Behav Immun. 58, 254\u201360 (2016).","journal-title":"Brain Behav Immun."},{"issue":"2","key":"41218_CR49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/infdis\/jiu437","volume":"211","author":"LL Barnes","year":"2015","unstructured":"Barnes, L. L. et al. Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals. J Infect Dis. 211(2), 230\u20137 (2015).","journal-title":"J Infect Dis."},{"issue":"7","key":"41218_CR50","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1532-5415.2006.00796.x","volume":"54","author":"AE Aiello","year":"2006","unstructured":"Aiello, A. E. et al. The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc. 54(7), 1046\u201354 (2006).","journal-title":"J Am Geriatr Soc."},{"issue":"1","key":"41218_CR51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/135502801300069773","volume":"7","author":"AR Marques","year":"2001","unstructured":"Marques, A. R. et al. Lack of association between HSV-1 DNA in the brain, Alzheimer\u2019s disease and apolipoprotein E4. J Neurovirol. 7(1), 82\u20133 (2001).","journal-title":"J Neurovirol."},{"issue":"0","key":"41218_CR52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1192\/bjp.124.3.273","volume":"124","author":"E Lycke","year":"1974","unstructured":"Lycke, E., Norrby, R. & Roos, B. E. A serological study on mentally ill patients with particular reference to the prevalence of herpes virus infections. Br J Psychiatry J Ment Sci. 124(0), 273\u20139 (1974).","journal-title":"Br J Psychiatry J Ment Sci."},{"issue":"6","key":"41218_CR53","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jalz.2014.07.157","volume":"11","author":"H L\u00f6vheim","year":"2015","unstructured":"L\u00f6vheim, H. et al. Herpes simplex infection and the risk of Alzheimer\u2019s disease-A nested case-control study. Alzheimers Dement. 11(6), 587\u201392 (2015).","journal-title":"Alzheimers Dement."},{"issue":"7","key":"41218_CR54","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/jnnp.44.7.651","volume":"44","author":"DM Mann","year":"1981","unstructured":"Mann, D. M., Yates, P. O., Davies, J. S. & Hawkes, J. Viruses, Parkinsonism and Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 44(7), 651 (1981).","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"5","key":"41218_CR55","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/ageing\/16.5.311","volume":"16","author":"EB Renvoize","year":"1987","unstructured":"Renvoize, E. B., Awad, I. O. & Hambling, M. H. A sero-epidemiological study of conventional infectious agents in Alzheimer\u2019s disease. Age Ageing. 16(5), 311\u20134 (1987).","journal-title":"Age Ageing."},{"issue":"11","key":"41218_CR56","doi-asserted-by":"crossref","first-page":"e3637","DOI":"10.1371\/journal.pone.0003637","volume":"3","author":"L Letenneur","year":"2008","unstructured":"Letenneur, L. et al. Seropositivity to herpes simplex virus antibodies and risk of Alzheimer\u2019s disease: a population-based cohort study. PloS One. 3(11), e3637 (2008).","journal-title":"PloS One."},{"issue":"6","key":"41218_CR57","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jalz.2014.04.522","volume":"11","author":"H L\u00f6vheim","year":"2015","unstructured":"L\u00f6vheim, H., Gilthorpe, J., Adolfsson, R., Nilsson, L.-G. & Elgh, F. Reactivated herpes simplex infection increases the risk of Alzheimer\u2019s disease. Alzheimers Dement. 11(6), 593\u20139 (2015).","journal-title":"Alzheimers Dement."},{"key":"41218_CR58","first-page":"P153","volume":"1","author":"C Helmer","year":"2015","unstructured":"Helmer, C. et al. Herpes simplex virus, anti-herpetic medication, and dementia: Results from the Three-city population-based cohort. Alzheimers Dement. 1, P153 (2015).","journal-title":"Alzheimers Dement."},{"issue":"11","key":"41218_CR59","doi-asserted-by":"crossref","first-page":"e0188490","DOI":"10.1371\/journal.pone.0188490","volume":"12","author":"M-C Tsai","year":"2017","unstructured":"Tsai, M.-C. et al. Increased risk of dementia following herpes zoster ophthalmicus. PloS One. 12(11), e0188490 (2017).","journal-title":"PloS One."},{"issue":"1","key":"41218_CR60","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neurobiolaging.2013.06.024","volume":"35","author":"I Carbone","year":"2014","unstructured":"Carbone, I. et al. Herpes virus in Alzheimer\u2019s disease: relation to progression of the disease. Neurobiol Aging. 35(1), 122\u20139 (2014).","journal-title":"Neurobiol Aging."},{"issue":"10","key":"41218_CR61","doi-asserted-by":"crossref","first-page":"e77921","DOI":"10.1371\/journal.pone.0077921","volume":"8","author":"G Westman","year":"2013","unstructured":"Westman, G. et al. Decreased proportion of cytomegalovirus specific CD8 T-cells but no signs of general immunosenescence in Alzheimer\u2019s disease. PloS One. 8(10), e77921 (2013).","journal-title":"PloS One."},{"issue":"4","key":"41218_CR62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/ageing\/13.4.205","volume":"13","author":"EB Renvoize","year":"1984","unstructured":"Renvoize, E. B. & Hambling, M. H. Cytomegalovirus infection and Alzheimer\u2019s disease. Age Ageing. 13(4), 205\u20139 (1984).","journal-title":"Age Ageing."},{"key":"41218_CR63","first-page":"988","volume":"15","author":"H L\u00f6vheim","year":"2015","unstructured":"L\u00f6vheim, H. et al. Cytomegalovirus infection does not increase the risk of alzheimer\u2019s disease. Neurodegener Dis. 15, 988 (2015).","journal-title":"Neurodegener Dis."},{"issue":"2","key":"41218_CR64","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11357-016-9890-5","volume":"38","author":"M Kawasaki","year":"2016","unstructured":"Kawasaki, M. et al. Carotid atherosclerosis, cytomegalovirus infection, and cognitive decline in the very old: a community-based prospective cohort study. Age Dordr Neth. 38(2), 29 (2016).","journal-title":"Age Dordr Neth."},{"issue":"3","key":"41218_CR65","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00002030-200002180-00023","volume":"14","author":"N Dupin","year":"2000","unstructured":"Dupin, N. et al. Relationship between Kaposi\u2019s sarcoma, Kaposi\u2019s sarcoma-associated herpesvirus and AIDS dementia complex. AIDS. 14(3), 333\u20135 (2000).","journal-title":"AIDS."},{"issue":"6","key":"41218_CR66","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.59.6.950","volume":"59","author":"S Polk","year":"2002","unstructured":"Polk, S. et al. A case-control study of HIV-1-related dementia and co-infection with HHV-8. Neurology. 59(6), 950\u20133 (2002).","journal-title":"Neurology."},{"issue":"17","key":"41218_CR67","first-page":"2354","volume":"12","author":"GJ Dore","year":"1998","unstructured":"Dore, G. J., Grulich, A., Law, M. G., Brew, B. J. & Kaldor, J. M. Kaposi\u2019s sarcoma and protection from AIDS dementia complex. AIDS. 12(17), 2354\u20135 (1998).","journal-title":"AIDS."},{"issue":"14","key":"41218_CR68","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1097\/00002030-199910010-00028","volume":"13","author":"M Mary-Krause","year":"1999","unstructured":"Mary-Krause, M. & Billaud, E. Impact of Kaposi\u2019s sarcoma in occurrence of opportunistic central nervous system disease. Clinical Epidemiology Group. AIDS. 13(14), 1985\u20137 (1999).","journal-title":"AIDS."},{"issue":"16","key":"41218_CR69","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/00002030-200111090-00012","volume":"15","author":"N Renwick","year":"2001","unstructured":"Renwick, N. et al. Kaposi\u2019s sarcoma and human herpesvirus 8 infection do not protect HIV-1 infected homosexual men from AIDS dementia complex. AIDS. 15(16), 2165\u20139 (2001).","journal-title":"AIDS."},{"issue":"9","key":"41218_CR70","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1212\/WNL.53.9.2032","volume":"53","author":"G Rezza","year":"1999","unstructured":"Rezza, G. et al. Does HHV-8 have a protective role on the development of HIV encephalopathy? Italian HIV-Seroconversion Study. Neurology. 53(9), 2032\u20136 (1999).","journal-title":"Neurology."},{"issue":"9","key":"41218_CR71","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1161\/01.STR.0000086754.32238.DA","volume":"34","author":"TE Strandberg","year":"2003","unstructured":"Strandberg, T. E., Pitkala, K. H., Linnavuori, K. H. & Tilvis, R. S. Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke. 34(9), 2126\u201331 (2003).","journal-title":"Stroke."},{"issue":"5","key":"41218_CR72","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/cid\/civ369","volume":"61","author":"JW Gnann","year":"2015","unstructured":"Gnann, J. W. et al. Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy. Clin Infect Dis. 61(5), 683\u201391 (2015).","journal-title":"Clin Infect Dis."},{"issue":"7","key":"41218_CR73","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1099\/vir.0.000128","volume":"96","author":"J Rovnak","year":"2015","unstructured":"Rovnak, J., Kennedy, P. G. E., Badani, H. & Cohrs, R. J. A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. J Gen Virol. 96(7), 1581\u2013602 (2015).","journal-title":"J Gen Virol."},{"key":"41218_CR74","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/JIR.S86958","volume":"9","author":"MR Bronzuoli","year":"2016","unstructured":"Bronzuoli, M. R., Iacomino, A., Steardo, L. & Scuderi, C. Targeting neuroinflammation in Alzheimer\u2019s disease. J Inflamm Res. 9, 199\u2013208 (2016).","journal-title":"J Inflamm Res."},{"issue":"8","key":"41218_CR75","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(09)70134-6","volume":"8","author":"D Gilden","year":"2009","unstructured":"Gilden, D., Cohrs, R. J., Mahalingam, R. & Nagel, M. A. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 8(8), 731\u2013740 (2009).","journal-title":"Lancet Neurol."},{"key":"41218_CR76","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","volume":"99","author":"WA Eimer","year":"2018","unstructured":"Eimer, W. A. et al. Alzheimer\u2019s disease-associated B-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron 99, 56\u201363 (2018).","journal-title":"Neuron"},{"key":"41218_CR77","doi-asserted-by":"crossref","unstructured":"Chen, V. C. et al. Herpes zoster and dementia: a nationwide population-based cohort study. J Clin Psychiatry. 79(1): pii: 16m11312 (2018).","DOI":"10.4088\/JCP.16m11312"},{"key":"41218_CR78","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13311-018-0611-x","volume":"15","author":"NS Tzeng","year":"2018","unstructured":"Tzeng, N. S. et al. Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex infections \u2013 a nationawide, population-based cohort study in Taiwan. Neurotherapeutics 15, 417\u2013419 (2018).","journal-title":"Neurotherapeutics"},{"issue":"3","key":"41218_CR79","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11357-017-9983-9","volume":"39","author":"AE Aiello","year":"2017","unstructured":"Aiello, A. E., Chiu, Y.-L. & Frasca, D. How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms? GeroScience. 39(3), 261\u201371 (2017).","journal-title":"GeroScience."},{"key":"41218_CR80","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbi.2015.10.014","volume":"52","author":"SD Gale","year":"2016","unstructured":"Gale, S. D., Erickson, L. D., Berrett, A., Brown, B. L. & Hedges, D. W. Infectious disease burden and cognitive function in young to middle-aged adults. Brain Behav Immun. 52, 161\u20138 (2016).","journal-title":"Brain Behav Immun."},{"issue":"13","key":"41218_CR81","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1212\/WNL.0b013e3182896e79","volume":"80","author":"M Katan","year":"2013","unstructured":"Katan, M. et al. Infectious burden and cognitive function: the Northern Manhattan Study. Neurology. 80(13), 1209\u201315 (2013).","journal-title":"Neurology."},{"issue":"8","key":"41218_CR82","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/jgs.13557","volume":"63","author":"CB Wright","year":"2015","unstructured":"Wright, C. B. et al. Infectious Burden and Cognitive Decline in the Northern Manhattan Study. J Am Geriatr Soc. 63(8), 1540\u20135 (2015).","journal-title":"J Am Geriatr Soc."},{"key":"41218_CR83","doi-asserted-by":"crossref","unstructured":"Granerod, J. et al. Increased rates of sequelae post-encephalitis in individuals attending primary care practices in the United Kingdom: a population-based retrospective cohort study. J Neurol. 264(2), 407\u201315 (1Feb 2017).","DOI":"10.1007\/s00415-016-8316-8"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41218-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41218-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41218-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T02:52:25Z","timestamp":1671245545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41218-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["41218"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-41218-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"3 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4743"}}